In this episode of the Spot On Podcast, host Peter Birch speaks with Associate Professor Rachel Roberts-Thomson who is a Medical Oncologist from Adelaide, about adjuvant and neoadjuvant therapies in melanoma care. 

Discussing what each therapy involves, adjuvant therapy given after surgery to lower the risk of recurrence, and neoadjuvant therapy given before surgery, particularly in patients with involved lymph nodes. Associate Professor Roberts-Thomson explains the clinical evidence supporting each approach, how decisions about treatment are made collaboratively between clinicians and patients, and the need for personalised care.

Outlining potential side effects of immunotherapy and targeted treatments, strategies for managing these effects, and practical aspects such as treatment scheduling and support for patients, including those in rural and remote areas. Reliable information sources and open communication with the healthcare team are said to be essential for effective decision-making.

The Spot On Podcast is brought to you by the Melanoma & Skin Cancer Advocacy Network (MSCAN), who are providing a new, innovative approach to tackle Australia’s national cancer. MSCAN engages with Australia’s leading clinicians, researchers and advocates with the aim of increasing the knowledge of those affected by a diagnosis. 

MSCAN is grateful to the clinicians interviewed in our podcast series. They have all provided their time and input freely and independently. 

The content discussed in these episodes is for information purposes only and should not be considered as medical advice. Please make sure you speak with a medical professional for advice relating to your own specific situation.